Literature DB >> 27887992

Does elevated progesterone on day of oocyte maturation play a role in the racial disparities in IVF outcomes?

Micah J Hill1, G Donald Royster2, Mansi Taneja3, Mae Wu Healy2, Shvetha M Zarek2, Alicia Y Christy2, Alan H DeCherney2, Eric Widra4, Kate Devine4.   

Abstract

The aim of this study was to evaluate if premature progesterone elevation on the last day of assisted reproduction technique stimulation contributes to racial disparities in IVF outcome. A total of 3289 assisted reproduction technique cycles were evaluated in Latino, Asian, African American, and white women. Live birth was more likely in white women (42.6%) compared with Asian (34.8%) and African American women (36.3%), but was similar to Latino women (40.7%). In all racial groups, progesterone was negatively associated with live birth and the negative effect of progesterone persisted when adjusting for confounders. Although the effect of elevated progesterone was similar in all racial groups, the prevalence of elevated progesterone differed. Progesterone > 1.5 ng/ml occurred in only 10.6% of cycles in white women compared with 18.0% in Latino and 20.2% in Asian women. Progesterone > 2 ng/ml occurred in only 2.3% of cycles in white women compared with 6.3% in Latino, 5.9% in Asian and 4.4% in African American women. The increased prevalence of premature elevated progesterone persisted when controlling for IVF stimulation parameters. In conclusion, premature progesterone elevation had a negative effect on live birth in all racial groups studied. The prevalence of elevated progesterone was higher in racial minorities. Published by Elsevier Ltd.

Entities:  

Keywords:  ART outcomes; ethnicity; racial disparity; serum progesterone level

Mesh:

Substances:

Year:  2016        PMID: 27887992      PMCID: PMC5292078          DOI: 10.1016/j.rbmo.2016.11.002

Source DB:  PubMed          Journal:  Reprod Biomed Online        ISSN: 1472-6483            Impact factor:   3.828


  33 in total

Review 1.  Racial and ethnic differences in reproductive potential across the life cycle.

Authors:  Samantha F Butts; David B Seifer
Journal:  Fertil Steril       Date:  2009-11-25       Impact factor: 7.329

2.  Elevated progesterone in GnRH agonist down regulated in vitro fertilisation (IVFICSI) cycles reduces live birth rates but not embryo quality.

Authors:  Robert Lahoud; Michele Kwik; John Ryan; Moamar Al-Jefout; Jane Foley; Peter Illingworth
Journal:  Arch Gynecol Obstet       Date:  2011-08-19       Impact factor: 2.344

3.  Cytochrome P450c17alpha gene (CYP17) polymorphism predicts use of hormone replacement therapy.

Authors:  H S Feigelson; R McKean-Cowdin; M C Pike; G A Coetzee; L N Kolonel; A M Nomura; L Le Marchand; B E Henderson
Journal:  Cancer Res       Date:  1999-08-15       Impact factor: 12.701

4.  Serum progesterone level effects on the outcome of in vitro fertilization in patients with different ovarian response: an analysis of more than 10,000 cycles.

Authors:  Bei Xu; Zhou Li; Hanwang Zhang; Lei Jin; Yufeng Li; Jihui Ai; Guijin Zhu
Journal:  Fertil Steril       Date:  2012-04-10       Impact factor: 7.329

5.  Is parental consanguinity associated with reduced ovarian reserve?

Authors:  Tanja Seher; Elisabeth Thiering; Majdah Al Azemi; Joachim Heinrich; Carsten B Schmidt-Weber; Coleen Kivlahan; Jan Gutermuth; Human M Fatemi
Journal:  Reprod Biomed Online       Date:  2015-06-16       Impact factor: 3.828

6.  Racial and ethnic disparities in assisted reproductive technology outcomes in the United States.

Authors:  Victor Y Fujimoto; Barbara Luke; Morton B Brown; Tarun Jain; Alicia Armstrong; David A Grainger; Mark D Hornstein
Journal:  Fertil Steril       Date:  2008-12-10       Impact factor: 7.329

Review 7.  The use of LH activity to drive folliculogenesis: exploring uncharted territories in ovulation induction.

Authors:  Marco Filicori; Graciela E Cognigni; Arafat Samara; Silvia Melappioni; Tiziana Perri; Barbara Cantelli; Lodovico Parmegiani; Giuseppe Pelusi; Domenico DeAloysio
Journal:  Hum Reprod Update       Date:  2002 Nov-Dec       Impact factor: 15.610

8.  Progesterone rise on the day of human chorionic gonadotropin administration impairs pregnancy outcome in day 3 single-embryo transfer, while has no effect on day 5 single blastocyst transfer.

Authors:  Evangelos G Papanikolaou; Efstratios M Kolibianakis; Cristina Pozzobon; Parikshit Tank; Herman Tournaye; Claire Bourgain; Andre Van Steirteghem; Paul Devroey
Journal:  Fertil Steril       Date:  2007-06-06       Impact factor: 7.329

9.  Does a frozen embryo transfer ameliorate the effect of elevated progesterone seen in fresh transfer cycles?

Authors:  Mae Wu Healy; George Patounakis; Matt T Connell; Kate Devine; Alan H DeCherney; Michael J Levy; Micah J Hill
Journal:  Fertil Steril       Date:  2015-10-09       Impact factor: 7.329

10.  The duration of pre-ovulatory serum progesterone elevation before hCG administration affects the outcome of IVF/ICSI cycles.

Authors:  Chu-Chun Huang; Yih-Ron Lien; Hsin-Fu Chen; Mei-Jou Chen; Chia-Jen Shieh; Yi-Lin Yao; Chin-Hao Chang; Shee-Uan Chen; Yu-Shih Yang
Journal:  Hum Reprod       Date:  2012-05-04       Impact factor: 6.918

View more
  3 in total

Review 1.  Adverse effect of prematurely elevated progesterone in in vitro fertilization cycles: a literature review.

Authors:  Michael B Evans; Mae W Healy; Alan H DeCherney; Micah J Hill
Journal:  Biol Reprod       Date:  2018-07-01       Impact factor: 4.285

Review 2.  The curious case of premature luteinization.

Authors:  Apostolos Kaponis; Elpiniki Chronopoulou; George Decavalas
Journal:  J Assist Reprod Genet       Date:  2018-07-26       Impact factor: 3.412

Review 3.  Revisiting debates of premature luteinization and its effect on assisted reproductive technology outcome.

Authors:  Reda S Hussein; Ihab Elnashar; Ahmed F Amin; Hisham A Abou-Taleb; Ahmed M Abbas; Ahmed M Abdelmageed; Tarek Farghaly; Yulian Zhao
Journal:  J Assist Reprod Genet       Date:  2019-10-25       Impact factor: 3.412

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.